Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Blood sugar & insulin stories

Nov 14, 2026

Eli Lilly releases new obesity drug clinical trial data at ObesityWeek

Eli Lilly released new clinical trial data for its obesity drugs at the ObesityWeek 2026 medical conference, showing weight loss benefits, though full results have not yet been published.

Nov 14, 2026·2 sources
00
Oct 29, 2026

Study links type 1 diabetes immune changes to potential cancer protection

New research published in The Journal of Immunology reveals how high blood sugar and type 1 diabetes may protect against certain cancers including melanoma, breast and colon cancer. The findings could inform development of new cancer immunotherapy treatments by explaining the previously mysterious association between T1D and decreased cancer risk.

Oct 29, 2026·1 source
00
Oct 28, 2026

Eli Lilly's retatrutide outperforms Ozempic in head-to-head diabetes trial

Eli Lilly announced its experimental obesity drug retatrutide delivered more than double the weight loss and superior blood sugar control compared to Novo Nordisk's Ozempic in a head-to-head clinical trial for type 2 diabetes.

Oct 28, 2026·3 sources
00
Sep 22, 2026

Roche's obesity drug enicepatide cuts body weight 15.5% in mid-stage trial

Roche's experimental obesity shot enicepatide reduced blood sugar and body weight by 15.5% in type-2 diabetes patients in a mid-stage trial, with a meaningful proportion reaching normalized glucose levels within less than a year of treatment.

Sep 22, 2026·2 sources
00
Aug 28, 2026

Keto diet reduced liver fat by 67% in clinical trial

A ketogenic diet outperformed Mediterranean and low-fat diets in reducing liver fat and improving metabolic health markers in a clinical trial of people with obesity, prediabetes, and fatty liver disease.

Aug 28, 2026·2 sources
00
Aug 18, 2026

Amylyx drug avexitide reduces severe low blood sugar episodes in post-bariatric surgery patients

Amylyx Pharmaceuticals' experimental drug avexitide met its primary endpoint in a Phase 3 trial for post-bariatric hypoglycemia, showing a 55% reduction in serious low blood sugar events compared to placebo in patients who experienced dangerously low blood sugar following weight-loss surgery.

Aug 18, 2026·2 sources
00
Apr 25, 2026

Continuous Glucose Monitors Significantly Improve Blood Sugar Control in Type 2 Diabetes Patients on Insulin

A major clinical trial found that real-time continuous glucose monitoring (CGM) significantly improves blood glucose management in adults with type 2 diabetes treated with basal insulin, offering evidence for expanded use of the technology beyond type 1 diabetes.

Apr 25, 2026·1 source
00
Apr 13, 2026

Genetic Variants Explain Why GLP-1 Drugs Like Ozempic Don't Work for 10% of Patients

New research reveals that approximately 10% of people carry specific genetic variants that make popular diabetes and weight-loss drugs like Ozempic and Wegovy significantly less effective, providing the first genetic explanation for variable drug response.

Apr 13, 2026·1 source
00
Apr 9, 2026

Study Links $35 Insulin Cap to Improved Treatment Adherence in Type 2 Diabetes

Research demonstrates that capping insulin costs at $35 per month significantly improves medication adherence among patients with type 2 diabetes, providing evidence for price control policies.

Apr 9, 2026·1 source
00

Top claims

  • ▪Adolescents taking Zepbound in Eli Lilly's SURMOUNT-ADOLESCENTS trial reported improvements in weight-related quality of life, including physical comfort and body esteem
  • ▪Eli Lilly plans to submit its late-stage trial results for Foundayo to the U.S. FDA by the end of 2026 for U.S. approval to treat moderate-to-severe obstructive sleep apnea
  • ▪In Eli Lilly's trial, Foundayo reduced the average apnea-hypopnea index at 52 weeks by 21.1 events per hour in patients not on positive airway pressure therapy compared to 4.8 for placebo and 18.3 with it compared to 5.5 for placebo

Subtopics

Drug Approval and Clinical Trials6Drug Policy, Pricing & Approval6Clinical trials5Metabolic health5Weight management4Lifestyle, Wellness and Nutrition3Biomarkers & bloodwork testing2Eli Lilly2GLP-1 / Weight-Loss Medications2GLP-1 medications2Nutrition fundamentals2Pharma2Weight loss drugs2Weight loss medications & GLP-1 drugs2Zepbound2Biomedical research1Cancer1Cancer & Oncology1Cancer immunotherapy1Cancer research1Diet & nutrition1Dietary patterns1Drug Classes & Treatment Access1Foundao1

Related timelines

Congress

110 stories

Trump administration

161 stories

Crypto hacks

100 stories

Russia-Ukraine war

136 stories

US midterm elections

102 stories